Unmasked neuropathic groin pain: risk of reoperation Authors: Kevin M Klifto, Miguel I Dorante, William D Henderson, David L Brown, Robert R Hagan Published: 2026 ABSTRACT AbstractBackgroundIdentifying factors associated with unmasked neuropathic groin pain after peripheral nerve surgery may clarify its pathophysiology and risks, reduce reoperations, and improve patient outcomes and satisfaction.MethodsWe retrospectively evaluated adults who underwent neurectomy between June 2006 and January 2025 for groin pain localized to the iliohypogastric nerve (IHN), ilioinguinal nerve (IIN), genital branch of the genitofemoral nerve (GBGFN), or lateral femoral nerve (LFN). Patients were stratified by whether they underwent reoperation for unmasked neuropathic pain in a new anatomical distribution. Outcomes were assessed using Numeric Rating Scale (NRS) and functional scores. Multivariate logistic regression identified independent predictors of reoperation. Minimum follow-up was 6 months.ResultsOf 273 patients, 255 (93.4%) patients did not require reoperations and 18 (6.5%) required reoperations for unmasked pain (median time to reoperation: 133 days). Among patients with unmasked pain, the most common initial pain distribution was that of the IIN (88.8%), whereas the most common unmasked distribution was that of the GBGFN (72.2%). GBGFN resection and muscle resection/transposition were associated with lower odds of reoperation. Lower BMI; pain, tingling, and/or burning in the scrotum, testicles, or labia; higher initial NRS scores for the “lowest” pain; and sharp pain were associated with greater odds of reoperation.ConclusionNeuropathic pain was unmasked at new locations following 6.5% of neurectomy procedures. Surgeons should reassess patients preoperatively for genital GBGFN pathology and consider including this nerve in operative plans when findings are subtle, potentially preventing reoperation. These data may also inform consent discussions.Keywords: Groin, Neuralgia, Neuropathic pain, Pelvic pain, Unmasked pain, Reoperation Introduction The primary goals of surgery for the treatment of neuropathic pain are to perform a single operation that eliminates pain while minimizing sensory loss and complications and maximizing postoperative function in activities of daily living.1 However, a small but meaningful proportion of patients may identify new areas of pain postoperatively, a phenomenon known as pain unmasking, which may prompt further evaluation and additional surgery.2 The phenomenon of masked pain explains how a more prominent pain signal prevents a patient from detecting a weaker pain signal carried by a different nerve through a “pain-inhibits-pain” pathway.3,4 This process occurs primarily at the level of the spinal cord.4 Unmasked neuropathic pain is diagnosed when a patient experiences pain in a new nerve distribution after neurectomy,2 with the perception that the original pain has “moved” to a new location. Identifying factors that contribute to unmasked postoperative neuropathic groin pain may help clinicians better understand its pathophysiology, reduce reoperation rates, and improve patient function and satisfaction. Our objective was to compare the characteristics of patients who underwent surgery for neuropathic groin pain and subsequently required reoperation for recurrent, unmasked groin pain with those of patients who did not require reoperation. Materials and methods We performed an Institutional Review Board approved retrospective analysis of all patients at a single center who underwent peripheral nerve surgery for groin pain between June 2006 and January 2025. The manuscript was prepared in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.5 Study population Patients included in this study were aged 18 years or older, had a diagnosis of neuropathic groin pain, underwent neurectomy for groin pain localized to one or more of the following lumbar plexus peripheral nerves: iliohypogastric (IHN), ilioinguinal (IIN), genital branch of the genitofemoral (GBGFN), lateral femoral (LFN), and had a minimum follow-up of 6 months. The groin was defined as the anatomical region encompassing the inferolateral abdomen, upper thigh, and pubis, with the groin crease forming its central axis.6 Neuropathic pain was defined as paresthesias and/or dysesthesias occurring secondary to a lesion or disease process involving the peripheral nervous system that generated abnormal somatosensory signals (Fig. 1).1 Diagnoses were confirmed before surgery using the constellation of symptoms, pain drawings, physical examination findings, and diagnostic nerve blocks. The operating surgeon performed ultrasound-guided nerve blocks with 0.25% bupivacaine and 1% lidocaine, targeting suspected offending nerves proximal to the painful area or presumed site of injury. Imaging, including radiography, ultrasonography, nerve conduction studies, computed tomography, and magnetic resonance imaging was used selectively, primarily to rule out other causes of pain. Cutaneous nerves of the groin region that may contribute to neuropathic pain, with their typical anatomical distributions of cutaneous innervation. A. Male. B. Female. Patients were stratified into two postoperative cohorts: those who underwent one or more reoperations for unmasked neuropathic groin pain and those who did not. Patients in the “unmasked” group developed new pain in a different anatomical nerve distribution after neurectomy. They were subsequently reevaluated using their clinical history, physical examination, and nerve blocks and were diagnosed with an injury to a different nerve. Patients often described their original pain as “not fixed but moved from one location to another.” Outcomes Patients were followed postoperatively in the clinic until their course was stable and discharge was considered appropriate. Some patients included in this study were contacted by telephone for additional follow-up to obtain longer-term outcome data. Pain severity was measured using the Numeric Rating Scale (NRS), ranging from 0 to 10, with 0 indicating no pain and 10 indicating the worst pain imaginable.7 Functional scores were recorded on a scale from 0 to 100%, with 0% indicating no physical function because of groin pain and 100% indicating full physical function without groin pain. Functional scores of <25% were considered poor; 25–49%, fair; 50–74%, good; and ≥75%, excellent. Patients were asked whether they believed the surgery was successful overall and whether they would recommend it to other patients. Statistical analyses Descriptive statistics were used to compare medians, interquartile ranges (IQR), odds ratios (OR), 95% confidence intervals (CI), frequencies, and percentages for variables and outcomes, given the non-parametric distribution of population data and small sample sizes. Differences between patients who underwent reoperation for unmasked groin pain and those who did not were assessed using Fisher exact tests for dichotomous variables and Mann-Whitney U tests for continuous and ordinal variables. Univariate analyses were followed by multivariate stepwise logistic regression with forward selection to identify independent predictors of reoperation for unmasked neuropathic groin pain. All statistical tests were two-tailed, with the threshold for statistical significance set at an α value of 0.05. Analyses were performed with IBM SPSS Version 30.0.0.0 (IBM Corporation, Armonk, NY). Results A total of 273 patients met the study criteria, were diagnosed with neuropathic sources of groin pain, and underwent surgery involving 543 peripheral nerves (LFN=171, IIN=160, IHN=132, GBGFN=80). Eighteen patients (6.5%) underwent reoperation for unmasked neuropathic groin pain in a new location. The anatomical distributions of groin pain at the initial evaluation were compared between patients who subsequently developed unmasked pain and those who did not (Table 1). Among patients with unmasked pain, the most common pain distribution at initial presentation was that of the IIN (n = 16/18, 88.8%), whereas the most common distribution of unmasked pain was that of the GBGFN (n = 13/18, 72.2%)(Fig. 2A and Fig. 2B). Table 1Incidence of involvement of each lumbar plexus peripheral nerve in groin pain, as identified at the initial evaluation and postoperatively, among patients who required reoperation for unmasked neuropathic groin pain and those who did not.Table 1 dummy alt textNo Reoperation for Pain (n = 255)Reoperation for Unmasked Pain (n = 18)NervesArea of Initial Groin Pain, n(%)Area of Initial Groin Pain, n(%)Area of Unmasked Groin Pain, n(%)IHN118 (46.2)14 (77.7)3 (16.6)IIN144 (56.4)16 (88.8)2 (11.1)GBGFN78 (30.5)2 (11.1)13 (72.2)LFN165 (64.7)6 (33.3)1 (5.5)FN0 (0)0 (0)2 (11.1)ON0 (0)0 (0)1 (5.5)LFN: lateral femoral nerve; IIN: ilioinguinal nerve; IHN: iliohypogastric nerve; GBGFN: genital branch of genitofemoral nerve; FN: femoral nerve; ON: obturator nerve. Percentages were calculated from the total number of patients from each column for neuropathic groin pain. Incidence of involvement of each lumbar plexus peripheral nerve in groin pain, as identified at the initial evaluation and postoperatively, among patients who required reoperation for unmasked neuropathic groin pain and those who did not. LFN: lateral femoral nerve; IIN: ilioinguinal nerve; IHN: iliohypogastric nerve; GBGFN: genital branch of genitofemoral nerve; FN: femoral nerve; ON: obturator nerve. Percentages were calculated from the total number of patients from each column for neuropathic groin pain. Anatomical distributions of neuropathic groin pain at the initial evaluation. Anatomical distributions of neuropathic groin pain unmasked postoperatively. Demographic characteristics were compared between patients who underwent reoperation for unmasked neuropathic groin pain and those who did not (Table 2). Only a lower median body mass index (BMI) was associated with a higher incidence of unmasked pain (26.8 kg/m2 [IQR: 21.4–29 kg/m2] vs. 29 kg/m2 [IQR: 25.7–33.2 kg/m2]; p = 0.014). The median interval from the initial operation to reoperation for unmasked groin pain was 133 days [IQR: 70–203 days]. Table 2Comparison of demographic characteristics between patients who required reoperation for unmasked neuropathic groin pain and those who did not.Table 2 dummy alt textNo Reoperation for Pain (n = 255)Reoperation for Unmasked Pain (n = 18)p-valueAge, years, median [IQR]49 [40-56]47 [39-54]0.734Sex, n(%)1.000 Male162 (63.5)12 (66.6) Female93 (36.4)6 (33.3)BMI, kg/m2, median [IQR]29 [25.7-33.2]26.8 [21.4-29]0.014Drug use, n(%)16 (6.2)1 (5.5)1.000Tobacco use, n(%)92 (36)4 (22.2)0.310Alcohol use, n(%)0.623 Never83 (32.5)4 (22.2) Occasional119 (46.6)10 (55.5) Socially42 (16.4)3 (16.6) Daily9 (3.5)1 (5.5)Comorbidities, n(%) HTN95 (37.2)6 (33.3)0.806 CAD11 (43.1)1 (5.5)0.568 Arrhythmia4 (1.5)0 (0)1.000 HLD39 (15.2)1 (5.5)0.487 Stroke5 (1.9)0 (0)1.000 DVT12 (4.7)0 (0)1.000 Diabetes32 (12.5)1 (5.5)0.707 OSA11 (4.3)0 (0)1.000 GERD70 (27.4)6 (33.3)0.593 Asthma23 (9)0 (0)0.379 COPD2 (0.7)0 (0)1.000 Kidney stones17 (6.6)3 (16.6)0.136 Cancer14 (5.4)0 (0)0.609 Gout13 (5.1)1 (5.5)1.000 Arthritis40 (15.6)1 (5.5)0.327 Rheumatoid arthritis2 (0.7)0 (0)1.000 Hyperthyroid2 (0.7)0 (0)1.000 Hypothyroid15 (5.8)0 (0)0.608 Other peripheral nerve compression40 (15.6)3 (16.6)1.000 Migraines28 (10.9)1 (5.5)0.703 Anxiety69 (27)7 (38.8)0.286 Depression74 (29)8 (44.4)0.189 Fibromyalgia4 (1.5)2 (11.1)0.053 Back pain115 (45)8 (44.4)1.000Family history, n(%) Cancer102 (40)8 (44.4)0.806 Diabetes mellitus107 (41.9)7 (38.8)0.811 Heart disease106 (41.5)7 (38.8)1.000 Blood clot10 (3.9)1 (5.5)0.537IQR: interquartile range, BMI: body mass index, HTN: hypertension, CAD: Coronary artery disease, HLD: hyperlipidemia, DVT: deep vein thrombosis, OSA: obstructive sleep apnea, GERD: gastroesophageal reflux disease, COPD: chronic obstructive pulmonary disease. Percentages were calculated from the total number of patients in each column. Comparison of demographic characteristics between patients who required reoperation for unmasked neuropathic groin pain and those who did not. IQR: interquartile range, BMI: body mass index, HTN: hypertension, CAD: Coronary artery disease, HLD: hyperlipidemia, DVT: deep vein thrombosis, OSA: obstructive sleep apnea, GERD: gastroesophageal reflux disease, COPD: chronic obstructive pulmonary disease. Percentages were calculated from the total number of patients in each column. Past number of specialists seen, operations, and diagnostic tests performed for the evaluation/treatment of groin pain were compared between the two groups (Table 3). Reoperations for unmasked pain were more highly associated with prior surgical procedures performed by a general surgeon (77.7%vs. 45.8%; p = 0.047)(Table 3). Table 3Comparison of the numbers of specialists previously consulted, operations performed, and diagnostic studies conducted before evaluation at our center between patients who required reoperation for unmasked neuropathic groin pain and those who did not.Table 3 dummy alt textNo Reoperation for Pain (n = 255)Reoperation for Unmasked Pain (n = 18)p-valueSpecialists, n(%) Urologist49 (19.2)3 (16.6)0.771 General surgeon117 (45.8)14 (77.7)0.047 OBGYN42 (16.4)6 (33.3)0.127 Orthopaedics82 (32.1)4 (22.2)0.311 Other surgeon+44 (17.2)2 (11.1)0.538 Pain management100 (39.2)10 (55.5)0.463Surgeries, n(%) Knee surgery42 (16.4)5 (27.7)0.210 Hip surgery26 (10.1)1 (5.5)1.000 Hysterectomy, oophorectomy, tubal ligation35 (13.7)4 (22.2)0.303 Vasectomy, orchiectomy, testicular surgery33 (12.9)2 (11.1)1.000 Inguinal hernia surgery103 (40.3)11 (61.1)0.136 Ventral hernia surgery23 (9)4 (22.2)0.090 Chest wall surgery4 (1.5)0 (0)1.000 C-section surgery21 (8.2)2 (11.1)0.655 Multiple abdominal surgeries90 (35.2)7 (38.8)0.802 Spine surgery37 (14.5)2 (11.1)1.000Diagnostics, n(%) Diagnostic nerve block109 (42.7)10 (55.5)0.334 CT abdomen83 (32.5)8 (44.4)0.418 CT pelvis69 (27)5 (27.7)0.306 MRI spine88 (34.5)8 (44.4)0.432 X-Ray hip56 (21.9)3 (16.6)1.000 EMG/NCS47 (18.4)2 (11.1)0.738Pain medications, n(%)183 (71.7)14 (77.7)1.000 Opioids97 (38)9 (50)0.313OBGYN: Obstetrics and Gynecology, CT: computed tomography, MRI: magnetic resonance imaging, EMG/NCS: Electromyography/Nerve Conduction Study. +Plastic and reconstructive surgery, Neurosurgery, Vascular surgery, Podiatry. Percentages were calculated from the total number of patients in each column. Comparison of the numbers of specialists previously consulted, operations performed, and diagnostic studies conducted before evaluation at our center between patients who required reoperation for unmasked neuropathic groin pain and those who did not. OBGYN: Obstetrics and Gynecology, CT: computed tomography, MRI: magnetic resonance imaging, EMG/NCS: Electromyography/Nerve Conduction Study. +Plastic and reconstructive surgery, Neurosurgery, Vascular surgery, Podiatry. Percentages were calculated from the total number of patients in each column. Pain symptoms and physical exam signs were compared between the two groups (Table 4, Table 5). Reoperations for unmasked pain were more highly associated with preoperative symptoms of stabbing pain (72.2% vs. 42.1%; p = 0.009), sharp pain (77.7% vs. 46%; p = 0.008), and pain, tingling, burning of the scrotum/testicles/labia (83.3% vs. 37.6%; p < 0.001)(Table 4). Reoperations were also increasingly associated with signs of IIN tenderness (100% vs. 55.8%; p < 0.001), IHN tenderness (94.4% vs. 44.1%; p < 0.001), and GBGFN tenderness (61.1% vs. 28.9%; p = 0.007)(Table 5). Table 4Pain characteristics of patients who required reoperation for unmasked neuropathic groin pain and those who did not.Table 4 dummy alt textNo Reoperation for Pain (n = 255)Reoperation for Unmasked Pain (n = 18)p-valueSymptom Laterality, n(%)0.718 Left88 (34.5)5 (27.7) Right124 (48.6)9 (50) Bilateral41 (16)4 (22.2)Duration of pain, years, median [IQR]1.2 [0.5-3]0.9 [0.6-1.9]0.467Pain description, n(%) Numbness138 (54.1)6 (33.3)0.185 Tingling114 (44.7)9 (50)0.596 Burning129 (50.5)10 (55.5)0.592 Stabbing108 (42.1)13 (72.2)0.009 Sharp118 (46)14 (77.7)0.008 Dull ache86 (33.5)10 (55.5)0.070 Constant154 (60.1)9 (50)0.791 Intermittent129 (50.3)8 (44.4)0.800Pain frequency, n(%) Seconds17 (6.6)0 (0)0.609 Minutes35 (14)2 (11.1)1.000 Hours55 (21.4)4 (22.2)1.000 Days30 (11.7)0 (0)0.225Pain, tingling, burning, n(%) Front or side of thigh162 (63.5)9 (50)0.434 Inner thigh89 (34.9)10 (55.5)0.071 Scrotum, testicles, labia96 (37.6)15 (83.3)<0.001Pain with orgasm, n(%)8 (3.1)2 (11.1)0.091Activities/positions make pain worse, n(%)176 (69)11 (61.1)0.404Activities/positions make pain better, n(%)153 (60)10 (55.5)0.774IQR: interquartile range. Percentages were calculated from the total number of patients in each column. Pain characteristics of patients who required reoperation for unmasked neuropathic groin pain and those who did not. IQR: interquartile range. Percentages were calculated from the total number of patients in each column. Table 5Physical examination findings in patients who required reoperation for unmasked neuropathic groin pain and those who did not.Table 5 dummy alt textNo Reoperation for Pain (n = 255)Reoperation for Unmasked Pain (n = 18)p-valueNerve involvement, n(%)LFN165 (64.4)11 (61.1)0.801 Tenderness164 (64)11 (61.1)0.803 Tinel sign137 (53.5)9 (50)0.808 Sensation abnormal83 (32.4)5 (27.7)0.797IIN144 (56.2)18 (100)<0.001 Tenderness143 (55.8)18 (100)<0.001 Tinel sign37 (14.4)5 (27.7)0.179 Sensation abnormal21 (8.2)3 (16.6)0.218IHN118 (46)17 (94.4)<0.001 Tenderness113 (44.1)17 (94.4)<0.001 Tinel sign26 (10.1)4 (22.2)0.129 Sensation abnormal17 (6.6)3 (16.6)0.140GBGFN78 (30.4)11 (61.1)0.016 Tenderness74 (28.9)11 (61.1)0.007 Tinel sign23 (8.9)2 (11.1)0.681 Sensation abnormal11 (4.2)1 (5.5)0.575Muscle involvement, n(%) Adductor origin23 (9)4 (22.2)0.089 Tenderness22 (8.6)4 (22.2)0.079 Provocative test positive13 (5)2 (11.1)0.259 Sensation abnormal3 (1.1)0 (0)1.000 Rectus abdominis insertion3 (1.1)1 (5.5)0.240LFN: lateral femoral nerve; IIN: ilioinguinal nerve; IHN: iliohypogastric nerve; GBGFN: genital branch of genitofemoral nerve. Percentages were calculated from the total number of patients in each column. Physical examination findings in patients who required reoperation for unmasked neuropathic groin pain and those who did not. LFN: lateral femoral nerve; IIN: ilioinguinal nerve; IHN: iliohypogastric nerve; GBGFN: genital branch of genitofemoral nerve. Percentages were calculated from the total number of patients in each column. Outcomes were compared between the two groups and summarized in Table 6. Patients who underwent reoperation for unmasked pain had higher median initial NRS scores for the “lowest pain within the last month” (6 [IQR: 4–7] vs. 4 [IQR: 2–6]; p = 0.029)(Table 6). However, median final NRS scores for the “lowest pain within the last month” were clinically similar between the groups (0 [IQR: 0–1] vs. 0 [IQR: 0–1]; p = 0.029)(Table 6). Median initial and final NRS scores for pain “at this very second,” “on average during the last month,” and “at its worst during the last month” were also similar between the groups. Despite undergoing reoperation for unmasked pain, patients had final functional scores similar to those of patients who did not undergo reoperation. Patients in both groups believed that surgery was successful overall and would recommend it to other patients (Table 6). Table 6Outcomes among patients who required reoperation for unmasked neuropathic groin pain and those who did not.Table 6 dummy alt textNo Reoperation for Pain (n = 255)Reoperation for Unmasked Pain (n = 18)p-valueNRS Pain Scores, median [IQR] This very second Initial6 [4–7]7 [6–8]0.051 Final0 [0–10]0 [0–2]0.476 Lowest last month Initial4 [2–6]6 [4–7]0.029 Final0 [0–1]0 [0–1]0.746 Average last month Initial6 [5–7]7 [6–8]0.065 Final0 [0–2]1 [0–2]0.742 Worst last month Initial9 [7–10]9 [8–10]0.728 Final1 [0–4]1 [0–3]0.987Final Functional Scores, median [IQR]95 [70-100]85 [63-99]0.136 Excellent185 (72.5)13 (72.2)0.852 Good43 (16.8)4 (22.2) Fair14 (5.4)1 (5.5) Poor13 (5)0 (0)Complications, n(%)19 (7.4)3 (16.6)0.167Complication requiring reoperation, n(%)4 (1.5)0 (0)1.000Infection, n(%)9 (3.5)2 (11.1)0.159Patient believed surgery was overall successful, n(%)227 (89)16 (88.8)1.000Patient would recommend surgery, n(%)231 (90.5)17 (94.4)1.000Total number of surgeries, median [IQR]1 [1-1]2 [2-3]<0.001Follow up duration, months, median [IQR]8 [6-55]90 [8-185]0.003IQR: interquartile range, NRS: Numeric Rating Scale. Percentages were calculated from the total number of patients in each column. Outcomes among patients who required reoperation for unmasked neuropathic groin pain and those who did not. IQR: interquartile range, NRS: Numeric Rating Scale. Percentages were calculated from the total number of patients in each column. Multivariate analyses were performed using significant findings to identify independent predictors of pain unmasking. Surgical resection of the GBGFN (OR: 0.031, 95%CI: 0.003–0.289; p = 0.002) and muscle resection/transposition (OR: 0.040, 95%CI: 0.002–0.667; p = 0.025) predicted lower odds of reoperation. Lower BMI (OR: 1.29, 95%CI: 1.05–1.59; p = 0.014), sharp pain (OR: 11.81, 95%CI: 1.101–138.45; p = 0.049), pain, tingling, or burning in the scrotum, testicles, or labia (OR: 89.76, 95%CI: 5.74–1403; p = 0.001), and higher initial NRS scores for the “lowest pain within the last month” (OR: 1.58, 95%CI: 1.09–2.28; p = 0.014) predicted greater odds of reoperation for unmasked groin pain. Discussion Unmasked pain reflects an interaction between overlapping peripheral nerve territories, nociceptive modulation within the central nervous system, and physiological changes associated with peripheral nerve injury. In this 20-year retrospective cohort, 6.5% of patients who underwent surgery for neuropathic groin pain developed unmasked neuropathic pain in a new nerve distribution that required reoperation. Although these data are limited to patients with groin pain, the phenomenon represents an important clinical consideration in the evaluation, surgical planning, and management of neuropathic pain in any anatomical region. Restricting the evaluation to one anatomical region also provided a more homogeneous population for comparison. The groin is particularly prone to diagnostic complexity because multiple sensory nerves from the lumbar plexus converge within a small anatomical region. The IHN, IIN, and GBGFN share overlapping dermatomal distributions across the lower abdomen, groin crease, proximal medial thigh, and genital regions.6 Pathology involving multiple nerves may coexist, although patients may perceive only the dominant nociceptive generator. In the present cohort, most patients who ultimately developed unmasked pain initially presented with symptoms in the IIN or IHN distributions, whereas postoperative unmasked pain often occurred in the GBGFN distribution. These findings suggest that concomitant GBGFN pathology may frequently be present but clinically overshadowed by stronger nociceptive signals from adjacent nerves. Given the number of patients affected, prophylactic resection of the GBGFN in patients with IIN or IHN pathology may be overly aggressive despite its low morbidity. However, these data support maintaining a high preoperative index of suspicion for GBGFN involvement and considering resection when clinically indicated. The neurophysiological basis of this phenomenon may be explained by diffuse noxious inhibitory controls (DNIC).3,4 Experimental studies have demonstrated that, through this pathway, a strong nociceptive stimulus suppresses competing, weaker nociceptive signals via descending inhibitory pathways within the central nervous system.3,4 At the dorsal horn, convergent nociceptive neurons receive input from multiple peripheral sources, and intense stimulation from one source can inhibit transmission from others.3 When the dominant pain generator is surgically eliminated, these inhibitory interactions resolve, allowing previously suppressed nociceptive signals to become perceptible.3 This mechanism may explain the shift in a pain distribution among patients who develop unmasked neuropathic pain after peripheral nerve surgery.2 Peripheral nerve injuries are common after surgical interventions and may contribute to iatrogenic pain. Transection, traction, thermal injury, ligation and/or postoperative scarring of sensory nerves can produce ongoing aberrant electrophysiological activity through sodium channel upregulation, ectopic impulse generation, and neuroma formation.8 Injured axons may develop spontaneous firing and cross-excitation between neighboring fibers, amplifying nociceptive signaling within the peripheral nervous system.9 In anatomically dense neural regions such as the groin, where multiple sensory branches traverse shared fascial planes, these interactions may facilitate communication between adjacent injured nerves.6 Eliminating a dominant pain generator may therefore expose signals from other sensitized nerves that were previously masked.2 Central sensitization likely represents another mechanism contributing to unmasked neuropathic pain. Persistent nociceptive input from peripheral nerve injuries can induce long-term plastic changes in dorsal horn neurons, including increased synaptic efficacy, expansion of neuronal receptive fields, and heightened responsiveness to sensory input.10 These changes may persist even after the primary peripheral stimulus is removed. Patients with long-standing neuropathic groin pain may therefore develop sensitized spinal circuits capable of amplifying signals from secondary peripheral nerves.3 Removal of the dominant nociceptive source may subsequently reveal additional sensory inputs that fall within these expanded receptive fields. Our cohort had low final NRS pain scores despite the need for reoperation, which may suggest that interventions were performed before central sensitization developed. Our multivariate analysis of surgical outcomes supports this pathophysiological framework. Sharp pain and genital sensory disturbances were strongly associated with reoperation for unmasked pain. These symptoms are characteristic of GBGFN involvement, suggesting that subtle concomitant GBGFN pathology may be present at initial presentation but masked by dominant pain signals from the IHN or IIN. Higher baseline NRS scores for the “lowest within the last month” also predicted unmasking, potentially reflecting greater peripheral and central sensitization that predisposes patients to perceive additional pain generators after treatment of the primary lesion. Surgical resection of the GBGFN was associated with significantly lower odds of reoperation for unmasked neuropathic groin pain. One possible explanation is that early identification and treatment of GBGFN pathology eliminates a common secondary pain generator that might otherwise become clinically apparent after treatment of adjacent nerves. Because the genital branch innervates highly sensitive structures of the scrotum and labia, even subtle pathology may become symptomatic after competing nociceptive signals are removed. Lower BMI was also associated with greater odds of unmasked pain. Although the explanation for this finding is unclear, patients with less subcutaneous tissue overlying the inguinal region may have less mechanical protection of small sensory nerves, potentially increasing their susceptibility to irritation, traction, or postoperative scar entrapment. Although unmasked neuropathic groin pain occurred in 6.5% of this surgical population, most patients experienced durable symptom improvement and high overall satisfaction after surgical treatment. These findings have important implications for the surgical management of neuropathic groin pain and may be applicable to neuropathic pain in other anatomical regions. Surgeons should recognize that successful treatment of a dominant peripheral pain generator may reveal additional neuropathic sources within overlapping sensory territories of the lumbar plexus. Comprehensive preoperative evaluations that include detailed pain mapping, nerve-specific physical examinations, and targeted diagnostic nerve blocks may help identify multiple contributing nerves before surgery. Although experienced peripheral nerve surgeons performed meticulous preoperative evaluations in this cohort, unmasking still occurred. Counseling patients about the possibility of unmasked pain is important for informed consent, establishing realistic postoperative expectations, and maintaining patient satisfaction. This study has limitations inherent to its retrospective design. The relatively small number of patients who developed unmasked pain and unequal cohort sizes limited statistical power and produced wide confidence intervals in multivariate analyses. Prospective validation is therefore needed. Among the surgical patients, 273 had at least 6 months of follow-up, whereas 130 had more than 12 months of follow-up. Of those with more than 12 months of follow-up, 15 developed unmasked pain and 115 remained pain-free. Long-term follow-up was difficult to obtain for patients whose pain resolved during the early postoperative period because many had little incentive to return. In addition, neuropathic pain is influenced by complex peripheral and central mechanisms that cannot be fully captured using retrospective clinical data. Advanced strategies, such as sequential selective nerve blocks during the same evaluation visit, high-resolution ultrasonography, and improved sensory mapping, may better identify concomitant nerve pathology in adjacent areas. In our current practice, the IIN and IHN are blocked first, regardless of whether GBGFN involvement is suspected. The GBGFN is then reexamined and assessed separately to determine whether pain or tenderness persists. If pain resolves after the IIN and IHN are blocked, only these nerves are excised. Some patients may subsequently require GBGFN excision. Because these patients often experience substantial pain relief after IIN and IHN blocks, pain signals from the GBGFN may not initially be perceived. In patients with persistent pain after IIN and IHN excision, the GBGFN may later be blocked, evaluated, and excised. A similar approach is used for the LFN. Overlapping sensory territories may reduce block specificity; consequently, an abnormality in a secondary nerve may remain clinically masked until after definitive treatment. Conclusions Neuropathic groin pain was unmasked following 6.5% of surgical neurectomy procedures. Lower BMI; preoperative sharp pain; tingling and/or burning in the scrotum, testicle, or labia; and higher initial NRS scores for the “lowest pain within the last month” predicted greater odds of reoperation for unmasked pain. In contrast, initial neurectomy of the GBGFN and muscle resection/transposition predicted lower odds of reoperation. These findings support meticulous diagnostic evaluation and a low threshold for considering additional concomitant neurectomy; they may also improve informed consent discussions, reduce reoperations, and improve outcomes. Ethical approval All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Approval was obtained from the University of Missouri Institutional Review Board (IRB#2101886). Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. References